Denali Therapeutics Inc (DNLI)
EBITDA Margin
-3465.59%
Quarterly · Period ending:
DNLI EBITDA Margin
Latest reported-3465.59%period ending
Latest reported-3465.59%period ending
DNLI Quarterly EBITDA Margin (0.00% → -3465.59%)
Quarterly ebitda margin
High-resolution chart · PNG
DNLI ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -3,465.5938% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -7,666.614% | |
| 63.126% | |
| -283.8109% | |
| -919.8969% | |
| -2,842.3153% | |
| -108.0316% | |
| -149.8327% | |
| -589.276% | |
| -1,559.1485% | |
| -254.9675% | |
| -872.2958% | |
| 77.7107% | |
| -617.0553% | |
| -1,011.322% | |
| -1,605.3829% | |
| -1,192.2731% | |
| -354.7854% | |
| -1,456.2783% | |
| -953.7455% | |
| 61.349% | |
| -2,982.1757% | |
| -3,369.3568% | |
| -3,883.6193% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |